177 related articles for article (PubMed ID: 11018075)
1. Complete antithrombin deficiency in mice results in embryonic lethality.
Ishiguro K; Kojima T; Kadomatsu K; Nakayama Y; Takagi A; Suzuki M; Takeda N; Ito M; Yamamoto K; Matsushita T; Kusugami K; Muramatsu T; Saito H
J Clin Invest; 2000 Oct; 106(7):873-8. PubMed ID: 11018075
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin: molecular basis of deficiency.
Bayston TA; Lane DA
Thromb Haemost; 1997 Jul; 78(1):339-43. PubMed ID: 9198176
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.
Jalbert LR; Rosen ED; Moons L; Chan JC; Carmeliet P; Collen D; Castellino FJ
J Clin Invest; 1998 Oct; 102(8):1481-8. PubMed ID: 9788960
[TBL] [Abstract][Full Text] [Related]
4.
Lu Z; Wang F; Liang M
Clin Sci (Lond); 2017 May; 131(9):823-831. PubMed ID: 28424376
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of inherited antithrombin III deficiencies.
Prochownik EV
Am J Med; 1989 Sep; 87(3B):15S-18S. PubMed ID: 2572168
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor gene disruption.
Broze GJ
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S89-92. PubMed ID: 9819035
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin and its inherited deficiency states.
van Boven HH; Lane DA
Semin Hematol; 1997 Jul; 34(3):188-204. PubMed ID: 9241705
[TBL] [Abstract][Full Text] [Related]
8. Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice.
Hayashi M; Matsushita T; Mackman N; Ito M; Adachi T; Katsumi A; Yamamoto K; Takeshita K; Kojima T; Saito H; Murohara T; Naoe T
J Thromb Haemost; 2006 Jan; 4(1):177-85. PubMed ID: 16409467
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic survey of 16 kindreds with hereditary antithrombin III deficiency.
Bock SC; Prochownik EV
Blood; 1987 Nov; 70(5):1273-8. PubMed ID: 3663935
[TBL] [Abstract][Full Text] [Related]
10. Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: evidence against a cause-effect relationship.
Pirisi M; Fabris C; Ceriello A; Soardo G; Giacomello R; Toniutto P; Vitulli D; Gonano F; Bartoli E
Acta Gastroenterol Belg; 1995; 58(2):230-7. PubMed ID: 7571984
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
12. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
[TBL] [Abstract][Full Text] [Related]
13. Developmental analysis of the Hba(th-J) mouse mutation: effects on mouse peri-implantation development and identification of two candidate genes.
Hendrey J; Lin D; Dziadek M
Dev Biol; 1995 Nov; 172(1):253-63. PubMed ID: 7589805
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
[TBL] [Abstract][Full Text] [Related]
15. Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT----TGT) and antithrombin III Glasgow (393 CGT----CAT).
Thein SL; Lane DA
Blood; 1988 Nov; 72(5):1817-21. PubMed ID: 3179448
[TBL] [Abstract][Full Text] [Related]
16. Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily.
Prochownik EV; Bock SC; Orkin SH
J Biol Chem; 1985 Aug; 260(17):9608-12. PubMed ID: 2991253
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
18. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
[No Abstract] [Full Text] [Related]
19. Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III gene.
Bock SC; Harris JF; Schwartz CE; Ward JH; Hershgold EJ; Skolnick MH
Am J Hum Genet; 1985 Jan; 37(1):32-41. PubMed ID: 2983542
[TBL] [Abstract][Full Text] [Related]
20. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.
Dewerchin M; Liang Z; Moons L; Carmeliet P; Castellino FJ; Collen D; Rosen ED
Thromb Haemost; 2000 Feb; 83(2):185-90. PubMed ID: 10739370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
